Search
Searching with a thematic focus on Trade Policy, WTO, WTO Doha
Showing 101-110 of 143 results
Pages
- Document
Export diversification in low-income countries: an international challenge after Doha
OECD Development Centre, 2003This paper discusses major policy issues related to commodity dependence and export diversification in low-income countries.DocumentBreaking the WTO logjam: towards enforceable special and differential treatment
id21 Development Research Reporting Service, 2002Should developing countries adopt the same trade rules as developed states – or should they be given Special and Differential Treatment (SDT)? Are existing SDT mechanisms out of synchronisation with emerging rules of trade policy? How can researchers assist the incorporation of achievable SDT regimes within the World Trade Organisation’s (WTO) rule-making process?DocumentGlobal economic prospects 2004: realising the development promise of the Doha agenda
Prospects for Development [World Bank], 2003This report presents a detailed overview of the world economy, and the near-term outlook. It also analyses central elements of the Doha Agenda that are important to developing countries.The overview of the world economy projects anaemic growth of 1.5 percent in 2003 in the industrialised world. It foresees better performance next year, as industrial countries' growth rises to 2.5 percent.DocumentMultilateral Environmental Agreements and the WTO
Chatham House [Royal Institute of International Affairs], UK, 2003This paper demonstrates that almost 30 Multilateral Environmental Agreements (MEAs) incorporate trade measures, regulating or restraining the trade in particular substances or products, either between parties to the treaty and/or between parties and non-parties.DocumentUS producers reap cotton subsidies and destroy African livelihoods
id21 Development Research Reporting Service, 2003Massive US cotton subsidies are encouraging over-production and export dumping and driving down world cotton prices. What are the consequences for producers in developing countries? Are US subsidies illegal under WTO rules? If they are allowed to continue, will this put an end to hopes that agricultural exports could lift Africans out of poverty?DocumentIntellectual property rights: food for the rich but poison for the poor?
id21 Development Research Reporting Service, 2003Can rules concerning intellectual property rights (IPRs) benefit developing countries and reduce poverty? How should IPR rules and regimes cover access to genetic resources? Are the costs involved in patent litigation a necessary price to pay for the incentives offered by the patent system?DocumentImplementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health
World Trade Organization, 2003Paragraph 6 of the Doha Declaration, which was agreed at the Fourth World Trade Organization (WTO) Ministerial conference in Doha in 2001, recognised that countries with insufficient or no pharmaceutical manufacturing capacities could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement.DocumentThe new “deal” on TRIPS and drugs: what does it mean for access to medicines?
Third World Network, 2003The Doha Declaration had confirmed the right of developing countries to use compulsory licences to override patents on medicines to allow generic drug manufacturers to produce cheaper versions of patented medicines. However, Ministers at Doha couldn’t agree on how developing countries without domestic pharmaceutical manufacturing capacity could effectively use compulsory licences.DocumentTRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha
Médecins Sans Frontières, 2003Public health advocates welcomed the Doha Declaration as an important achievement because it gave primacy to public health over private intellectual property, and clarified World Trade Organization (WTO) Members' rights to use trade-related aspects of intellectual property rights (TRIPS) safeguards.DocumentDoha derailed: a progress report on TRIPS and access to medicines
Médecins Sans Frontières, 2003Since Doha, some Members of the World Trade Organization (WTO) have attacked both the spirit and intent of the Doha Declaration, putting the interests of their pharmaceutical industries ahead of the health of the world’s poor.Pages
